pubmed-article:15821467 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15821467 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15821467 | lifeskim:mentions | umls-concept:C0278678 | lld:lifeskim |
pubmed-article:15821467 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
pubmed-article:15821467 | lifeskim:mentions | umls-concept:C0041365 | lld:lifeskim |
pubmed-article:15821467 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:15821467 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:15821467 | pubmed:dateCreated | 2005-4-11 | lld:pubmed |
pubmed-article:15821467 | pubmed:abstractText | Approximately 30% of renal cell carcinomas (RCCs) present as metastatic disease. Molecular markers have the potential to characterize accurately the biological behavior of tumors and they may be useful for determining prognosis. | lld:pubmed |
pubmed-article:15821467 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15821467 | pubmed:language | eng | lld:pubmed |
pubmed-article:15821467 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15821467 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15821467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15821467 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15821467 | pubmed:month | May | lld:pubmed |
pubmed-article:15821467 | pubmed:issn | 0022-5347 | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:GueJ WJW | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:FiglinRobert... | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:BelldegrunAri... | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:YuHongH | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:KimHyung LHL | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:SeligsonDavid... | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:JanzenNicolet... | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:LiuXueliX | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:HorvathSteveS | lld:pubmed |
pubmed-article:15821467 | pubmed:author | pubmed-author:BuiMatthew... | lld:pubmed |
pubmed-article:15821467 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15821467 | pubmed:volume | 173 | lld:pubmed |
pubmed-article:15821467 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15821467 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15821467 | pubmed:pagination | 1496-501 | lld:pubmed |
pubmed-article:15821467 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:meshHeading | pubmed-meshheading:15821467... | lld:pubmed |
pubmed-article:15821467 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15821467 | pubmed:articleTitle | Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. | lld:pubmed |
pubmed-article:15821467 | pubmed:affiliation | Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA. | lld:pubmed |
pubmed-article:15821467 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15821467 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:15821467 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:50557 | entrezgene:pubmed | pubmed-article:15821467 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15821467 | lld:pubmed |